Lymphatic invasion is a significant indicator of poor patient prognosis in lung squamous cell carcinoma

about

Lymphatic invasion is a significant indicator of poor patient prognosis in lung squamous cell carcinoma

Item

http://www.wikidata.org/entity/Q42314413

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Lymphatic invasion is a signif ...... n lung squamous cell carcinoma

@en

Lymphatic invasion is a signif ...... n lung squamous cell carcinoma

@nl

type

Item

label

Lymphatic invasion is a signif ...... n lung squamous cell carcinoma

@en

Lymphatic invasion is a signif ...... n lung squamous cell carcinoma

@nl

prefLabel

Lymphatic invasion is a signif ...... n lung squamous cell carcinoma

@en

Lymphatic invasion is a signif ...... n lung squamous cell carcinoma

@nl

P1476

Lymphatic invasion is a signif ...... n lung squamous cell carcinoma

@en

P2093

Atsushi Wada

http://www.w3.org/2001/XMLSchema#string

Daisuke Masuda

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kijima

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Kobayashi

http://www.w3.org/2001/XMLSchema#string

Kenei Nakazato

http://www.w3.org/2001/XMLSchema#string

Madoka Nito

http://www.w3.org/2001/XMLSchema#string

Makiko Tanaka

http://www.w3.org/2001/XMLSchema#string

Masayuki Iwazaki

http://www.w3.org/2001/XMLSchema#string

Ryota Masuda

http://www.w3.org/2001/XMLSchema#string

Sadaki Inokuchi

http://www.w3.org/2001/XMLSchema#string

P2860

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression.

Pemetrexed versus gefitinib versus erlotinib in previously treated patients with non-small cell lung cancer

Significant prognostic factors in patients with early gastric cancer.

Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.

Pemetrexed in the treatment of advanced non-squamous lung cancer.

Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease.

Tumor budding is a significant indicator of a poor prognosis in lung squamous cell carcinoma patients

Clinical significance of wall invasion pattern of subserosa-invasive gallbladder carcinoma.

Tobacco use in relation to COPD and asthma.

P304

2067-2073

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MMR.2017.6256

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28260029

http://www.w3.org/2001/XMLSchema#string

P932

5364981

http://www.w3.org/2001/XMLSchema#string